HOME › DRUGS › REGADENOSON
ACTIVE SUBSTANCE / INN

REGADENOSON

Brand name(s): LEXISCAN, Rapiscan, REGADENOSON
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA022161
Myocardial Perfusion Imaging
ACTIVE SUBSTANCE
Regadenoson
REGULATORS
FDA · EMA
SPONSORS / MAH
GE HEALTHCARE, ASTELLAS, GE Healthcare AS 
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
REGADENOSONANDA207320GLANDPrescription
LEXISCANNDA022161ASTELLASPrescription
REGADENOSONANDA215955GE HEALTHCAREDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RapiscanGE Healthcare AS Authorised06/09/2010Myocardial Perfusion Imaging

FULL INTELLIGENCE ON REGADENOSON

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →